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INTRODUCTION
Pyruvate dehydrogenase complex (PDC) occupies a key position
in intermediate metabolism by oxidatively decarboxylating pyruvate
to acetyl-CoA, an irreversible step in the utilization of
carbohydrate. PDC is a classic example of a multienzyme complex.
As isolated from most sources, three distinct components function in
the overall reaction. The pyruvate dehydrogenase component of the
complex, termed El, uses thiamin pyrophosphate as an essential
cofactor. Dihydrolipoyl transacetylase component, designated E2 has
a lipoic acid cofactor attached to it. Dihydrolipoyl dehydrogenase
is designated E3 and contains an FAD cofactor.
The E2 component of the complex has three major roles: (1) it
forms the central core around which are arranged multiple copies of
the El and E3 components
, (2) it provides attachment sites for the
lipoic acid cofactor, and (3) it catalyzes the reaction which forms
the acetyl-CoA product [1]. The E2 subunits of the mammalian
complex are arranged as a pentagonal dodecahedron which has 532
symmetry with 60 copies of the dihydrolipoyl transacetylase
component
.
E2 has several functional domains which includes a compact
inner domain and an extended outer domain. The inner domain
contains the active site which catalyzes the transacetylase
reaction. One or more outer domains containing a lysine group with a
lipoic acid group attached via a thioester linkage is present in
different E2's. The lipoic group region moves between the active
sites of the El, E2 (transacetylase) and E3 components. Between the
inner domain and extended outer domains there is a region called the
binding domain. In E. coli this distinctive region is thought to
bind the E3 component to the complex [3]. The three domains are
joined by linker regions shown to be high in proline and alanine
giving them increased flexibility [4]. This is analogous to
mammalian PDC where the linker region sequence has been derived but
the function has not been proven.
El and E3 components are less complicated enzymes in
structure relative to E2. E3 is an FAD containing flavoprotein and
contains a disulfide bridge which undergoes oxidation and reduction
during catalysis. The Porcine heart E3 sequence has been derived
and the subunit has 49,690 Mr [51. El is a tetramer consisting of 2
non-identical subunits; a and $.
The kinase and phosphatase acting on PDC are specific to the
complex [6]. The kinase subunits are tightly bound to and copurify
with PDC while the PDC phosphatase is loosely associated and is
purified as a distinct soluble enzyme [7]. The kinase consists of
two non identical subunits termed Kc and and is apparently a
dimer [7]. The Kc subunit (46,00 Mr) contains the kinase active
site and the subunit (43,000 Mr) is thought to be regulatory.
The bovine PDC phosphatase consists of two subunits with the
catalytic activity residing in the smaller (49,000 Mr). The larger
subunit (89,000 Mr) contains an FAD cofactor [8] but the function of
this has not been determined.
In mammalian PDC, there is a component identified as protein
X [9] [10] which is tightly bound to E2. Initially it was assumed
[2] that protein X was a proteolytic fragment of E2 but evidence has
shown that protein X is a distinct component [9] [10]. Protein X
contains at least one lipoyl moiety which like E2 lipoyl groups can
be reductively acetylated [9]. It was suggested that protein X is
responsible for binding PDC kinase but this was not firmly
established.
Since it was not clear how protein X is bound to the core, I
hoped to gain some knowledge of this by looking how protein X
separates from the core. I wished to develope techniques to remove
protein X away from the E2 core and then to evaluate the properties
of the E2 core that is lacking in protein X and if possible totally
free of protein X. I hoped to learn how the removal of protein X
affects the activity of the E2 core enzyme and how it affects the
PDC complex as a whole.
EXPERIMENTAL PROCEDURES
Materials . Highly purified bovine kidney pyruvate dehydrogenase
complex (15-18 micromole/mg/min) was prepared by the procedure
developed by Roche and Cate (1977) [11]. The E2-X-KcKb and El
components were prepared under the procedure of Linn et al [6]. The
E2—Xj was prepared by selectively removing the lipoyl bearing domain
of protein X by treatment with protease Arg C [12]. Porcine heart
E3 was purchased from Sigma Chemical Company. Bovine serum albumin
(BSA), used as a protein standard, was purchased from U.S.
Biochemical Corp. [ 3-^C ] pyruvate and [ 1-^C ]acetyl-CoA were
purchased from New England Nuclear, Du Pont Co. All other materials
were of the highest grade possible.
Sodium dodecvl sul f ate-polyacrylamide gel electrophoresis (SDS-
PAGE)
.
SDS-PAGE was conducted using the Laemmli System. [18]
Staining was with Coomassie Blue G-250 formulated under 3.11.3 of
Neuhoff et al
.
PDC Reconstitution Assay . The NAD+ reduction activity of the
pyruvate dehydrogenase complex was determined at 30°C by monitoring
the increase in absorbanceat 340 nm [6], The assay mixture
consisted of 50 mM potassium phosphate buffer pH 7.3-7.5, 0.2 mM
thiamin pyrophosphate, 1.0 mM of Coenzyme A, 2.6 mM cysteine
hydrochloride, 2.0 mM of pyruvate and enzyme. For assaying
reconstituted complex, the incubation mixture included 1.0 Ug E2
source was incubated with 0.5 ug E3 (dihydrolipoyl dehydrogenase
component) and 1.0 ug El (pyruvate dehydrogenase component) in a
total of 15 ul 50 mM potassium phosphate buffer for 5 min at 4 C
before adding 10 ul to the assay cuvette. Activity was expressed as
umoles of NADH formed per minute per mg of enzyme. The E2-X-KcKb
subcomplex was used as an E2 and X source in control assays.
El acetylation assay . Acetylation of the lipoyl moieties of E2 by
[3-14C] pyruvate was measured at 4° and 22° C [9]. At 4°C, El and E2
were incubated for 5 minutes with 125 uM TPP and 1.0 mM MgCl2 and
diluted 5 fold into reaction mixture with final concentrations of
250 uM [3-14C] pyruvate, 25 uM TPP , 200 uM MgCl 2 and 50 mM KxP04 pH
7.3. At 22°C all conditions were kept the same except El and E2
were preincubated with 12.5 mM TPP prior to dilution into assay
mixture. The final concentration of TPP was 2.5 uM. At timed
intervals samples were removed and spotted on TCA soaked discs which
were subsequently washed 4X with 10% TCA (trichloroacetic acid) for
30 minutes followed by two 5 minute washes with absolute ethanol and
two 3 minute washes with ether under hood. Discs were placed in
scintillation fluid and protein bound radioactivity was measured.
Non—radioactive transacetylation assay . This assay was used as a
rapid method for determining activity during resolution steps.
Dihydrolipoyl transacetylase (E2) transfers the acetyl group of
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acetyl-CoA to dihydrolipoamide and the S-acetyldihydrolipoamide (S-
acetyl DHL) product is measured spectrally at 232 run. Activity is
measured in the presence of a low level of acetyl-CoA that is
constantly being regenerated by a reaction transferring the acetyl
group from acetyl phosphate to CoA which is catalyzed by
phosphotransacetylase (PTA). The reaction mixture consists of 1-5 ul
of PTA (1,000 units per ml), 30 mM TRIS-HC1 pH 7.5, 1.0 mM
dihydrolipoamide (DHL), 1.0 mM acetylphosphate, 5 mM cysteine, and
5 mM CoA in a total volume of 1 ml. The reaction mixture without
addition of enzyme proceeds until there is no further increase in
A-232 ^ue to tne formation of acetyl—CoA and then E2 source is added.
The increase in absorbance at 232 nm due to formation of S—acetyl
DHL is measured and the activity reported as AOD/min.
Radioactive dihydrolipoyl transacetylase assay . Radioactive
S-acetyl DHL formed from reaction of [ l-^^C]acetyl-CoA with DHL was
extracted into benzene leaving the unreacted in the aqueous phase
[14]. The reaction mixture consisted of 0.25 ml 50 mM potassium
phosphate pH 7.4, 0.1 ml of 2.5 mM DHL in 25% ethanol , 0.1 ml of 2.5
mM [ l-^Clacetyl-CoA (~700 cpm/pmol ) ,and 4-10 ug of E2 source.
Deionized water was added to make the total volume of the assay 0.5
ml. The reaction was started by the addition of the [ 1-^C ]acetyl-
CoA and incubated at room temperature for 2 min. 1 ml of cold
benzene was added and vortexed for 30 sec to stop the reaction and
to initiate the extraction of the S-acetyldihydrolipoamide. All
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sample were again vortexed and then centrifuged at room temperature
in a clinical centrifuge at 1500 rpm for 5 min to separate layers.
0.2 ml of the benzene phase was withdrawn and radioactivity measured
in a Beckman liquid scintillation counter. Control differed by
lacking the addition of enzyme. Activity was expressed in
umoles/min/mg.
Binding of El and E3 components to E2 source . In 110 ul of 50 mM
sodium phosphate buffer pH 7.5 containing 0.2 mM EDTA and 5 mM DTT,
30 ug of El was incubated with three different E2 sources (E2-X-
KcKb , E2-Xj, and E2 oligomer) for 10 min. at 4° C [15]. Control
samples consisted of each E2 source alone and 30 ug of El alone.
The entire sample was layered over a three step sucrose gradient
(20 yl each of 7.5%, 10% and 15% sucrose dissolved in the same
buffer). The samples were centrifuged in a rotor, tube and adaptor
in a Beckman Ultracentrifuge at 130,000 g for 120 min. The upper
150 ul was removed and designated the first supernatant. The rest
of the supernatant was removed and designated the second
supernatant. The pellet was dissolved in 50 ul of sample buffer and
SDS PAGE was conducted using 15 ul of 1st supernatant and 5 ul of
pellet. The gel was stained with Coommassie Blue stain and
photographed
.
Conditions for evaluating E3 binding to the same E2 core were
the same as those used for El above except only 10 Ug of E3 was
incubated with the E2 source and the centrifugation time was
extended to 180 min at 130,000g.
O-phthaldehyde (OPA) protein measurement . The protein concentration
of each pellet and supernatant was determined by the procedure of
Fried et al (1984) [20] using fluorescence of OPA reacting with the
available amino and thiol groups of the protein. This sensitive
assay system combines the OPA derivatization procedures and the
separation of fluorescent protein-SDS complexes from the interfering
fluorescence of small molecular weight products using a 10 inch size
exclusion TSK columns. Excitation and emission wavelengths were 330
nm and 418 nm, respectively. The assay was linear over the range of
3 ng to 1 ug of protein. For our purposes, a BSA standard curve was
used in the range of 0.2 ug up to 1.0 ug.
BCA protein measurement . A set of BSA protein standards were
prepared in 50 mM phosphate buffer pH 7.5 ranging from 0.25 ug to 2
Ug per 10 ul. 10.0 ul of each standard (final ug ranging from 0.25
Ug to 2.0 ug) and sample were placed into wells of a 96 well ELISA
assay plate [16]. The working reagent was prepared by mixing
Reagent A with Reagent B in a ratio of 50:1. 200 ul of working
reagent was added to each well. Blanks consisted only of buffer and
working reagent. The plate was covered and incubated at 60° C for
30 minutes, cooled and absorbance read at 590 nm.
Microplate Binding Assay
.
Samples of E2-X subcomplex (or other
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fractions to be tested for binding) were incubated in 100 ul of
phosphate buffered saline (PBS: 8 mM ^HPO^, 1.15 mM KH2PO4, 2.6 mM
KC1, 136 mM NaCl , and 0.2 mM EDTA) for 14 hours at 6° C in the wells
of a 96 well ELISA plate [19]. Following 4 washes with 100 ul PBS,
the level of protein bound was measured in quadruplicate using
Pierce BCA [16]. A parallel set of wells treated with 200 ul of PBS
containing 1% (w/v) ovalbumin for 4 h. Following two washes with
PBS, 2.0 ug of E3 in 100 ul PBS containing 1 mg/ml ovalbumin was
added to the wells and incubated for 40 minutes at 23°C. Control
wells were blocked with 1% (w/v) ovalbumin in PBS and treated with
the 2.0 ug E3 component. Two rapid washes with PBS containing 1
mg/ml ovalbumin were performed and then dihydrolipoyl dehydrogenase
activity measured by adding 200 ul of 50 mM potassium phosphate (pH
7.5) containing 1.0 mM NAD+
,
1.0 mM dihydrolipoamide, and 0.5 mM
EDTA. At the indicated time, 190 ul aliquots were removed and the
reaction quenched by the addition of 190 ul of 2M guanidine-HCl in
50 mM potassium phosphate pH 7.5 at 4° C and thoroughly mixed. The
absorbance at 340 nm was measured in a Beckman DU 8 spectrometer.
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RESULTS
Initial E2 oligomer resolution
E2—X—KqK]-, is composed of ~ 60 E2 subunits (associated to form a
pentagonal dodecahedron), ~6 protein X subunits and 2-3 PDH kinases
dimers. The E2-X-KcKb subcomplex was incubated in various
concentrations of urea and NaCl for different lengths of time. The
objective was to try to separate an oligomeric E2 component from
protein X and the KcKb components. This treated subcomplex was then
applied to a 0.7 x 45 cm Sephacryl S-300 or a S-400 gel filtration
column equilibrated with the same level of chaotropic reagents. The
protein content of the fractions collected from the column was
determined by the absorbance at 280 nm was measured using the column
buffer as a blank. Dialysis was conducted, protein concentration was
determined and SDS-PAGE conducted to estimate the extent of
separation of protein X away from the E2 component.
The initial resolution attempts were conducted using 2 M and
5 M concentrations of urea in 50 mM sodium phosphate buffer pH 7.4
containing 0.5 mM DTT. The period of incubation in these buffers
was 30 minutes at 4° C prior to the gel filtration step. The eluent
buffer on the column was the same as the incubation urea buffer
except it contained 0.2 mM EDTA as well. The fractions collected
from the 2 M urea column showed little separation between
components. The 5 M urea column showed significant separation of
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protein X away from the E2 core. The later (downstream) fractions
showed an increased ratio of X to E2 compared to the standard E2-X-K
subcomplex (Figure 2).
In order to increase the resolution of protein X from the E2
core, the urea concentration was increased to 6 M and the gel
filtration was again conducted. SDS-PAGE showed only a trace amount
of X appeared in the upstream fractions that contained E2 (Figure
3). Protein measurements were performed using the OPA method.
Spectrophotometric assays were performed using E2-X-KCK^ as a
standard. The E2 activity (S—acetyl—DHL measured at 232 nm) of the
fractions containing low ratios of protein X vs. E2 had
substantially decreased the specific activity for E2. The yield off
the column was less than 50% of the initial protein used in the
incubation.
A study of the effects on the E2 activity of E2-X-KcKb
subcomplex following the treatment with various concentrations of
urea was performed. Treatment with 5 M urea decreased E2 specific
activity 10% vs. untreated E2-X-KcKb subcomplex. However, a large
decline in E2 specific activity was caused by the treatment in 6 M
urea, probably due to the unfolding of the E2 subunits. Compromising
urea concentration levels were picked at 5.5 M and an additional pH
variable was added. Two sets of resolutions were performed using pH
6.5 and pH 8.5 both using 5.5 M urea concentrations. Separation of
protein X from E2 was not complete and transacetylation specific
activity held steady with that of E2-X-KcKb.
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Modifications in resolution procedure.
Variations in resolutions using the same urea concentration
caused a re—evaluation of the resolution variables. Further studies
concluded that urea concentrations were optimal at 5.5 M. Anything
higher caused a decrease in transacetylation specific activity.
Concentrations lower than 5.0 M urea decreased the efficiency of the
resolution. In an attempt to keep the separation high without
decreasing transacetylation activity, the column matrix was replaced
with Sephacryl S-400 and 0.5 M NaCl was added to the incubation
buffer and column buffer while the urea concentration was held at
5.5 M.
With the addition of the NaCl to the resolution protocol,
the separation of protein X from the E2 fraction was greatly
improved. Transacetylation specific activity of the resolved E2
remained comparable with E2-X-KcKb subcomplex specific activity. E2
fractions with little or no protein X were combined and the
oligomeric core pelleted together. E2 fractions with increased
levels of protein X were also combined and pelleted. The purpose of
the centrifuging the fractions was to bring down into the pellet the
oligomeric assembled units and more native E2 components while
leaving the unfolded or non native components in the supernatant.
Reconstitution PDC activity assays were performed. The PDC activity
of the E2 oligomer freed of most of the protein X was only 20% of
that found from E2-X-KcKb starting material. Thus while the
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transacetylation specific activity had not decreased, either the
lack of protein X or the structural modifications of E2 resulting
from the resolution process were limiting the reconstitutional PDC
activity.
In addition, the yield from the treatment of 1 mg E2-X-KcKb
was quite low with approximately 400 ug of protein eluting from the
column and only 100 Ug of the E2 oligomer freed of protein X was
recovered
.
Addition of Pluronic F-68.
PIuronic F—68, a block polymer with an average composition
of H(OCH2CH2)75-(OCH(CH3)CH2)30-(OCH2CH2O)7 5H, was tested to see if
it would improve the yield off the column. The basic concept behind
the use of Pluronic F-68 was that the hydrophobic center of the
block polymer would interact with the exposed hydrophobic regions of
the enzyme components preventing the E2-X-KcKb from interacting with
the hydrophobic areas of the column matrix and therefore increase
the protein yield off the column. PDC pretreated with Pluronic F-68
was evaluated for retention of activity and found that there was no
effect on PDC when incubated with different levels of Pluronic F-68
in the range of 0.5 mg/ml up to 10 mg/ml.
A resolution of E2-X-KcKt> was conducted with 5.3 M urea and
0.35 M NaCl in which Pluronic F-68 was added to both the incubation
mixture and the elution buffer at a concentration of 1 mg/ml. The
results of this addition was to decrease in separation of the
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protein X from the E2. Another resolution was then conducted in
which Pluronic F— 68 was added only to the column buffer at a
concentration of 0.2 mg/ml with no Pluronic F-68 added to the
incubation mixture (Figure 4). This gave the best results. Protein
recovery increased to close to 700 ug of total protein from the
column when starting material was 1 mg E2-X-KcK]-) (Table 1). About
250 ug of protein was recovered in the E2 pellet with the addition
of Pluronic F-68 in the column buffer.
There was still some variations between resolutions in
amount of separation and contamination of E2 fractions with protein
X. Holding the other variables (urea, NaCl, and Pluronic
concentrations) constant the time of incubation was increased from 1
hour to 90 minutes up to the final time of 2 hours. By increasing
the incubation time to two hours, separation of protein X from E2
was greatly improved without decreasing E2 specific activity.
Optimal resolution conditions
After all conditions were optimized, the final protocol for
the pre-incubation consisted of 50 mM sodium phosphate pH 7.5, 0.5
mM DTT, 5.3 M urea, 0.35 M NaCl with 1-2 mg E2-X-K incubated for 2
hours at 4° C. Table 2 shows the summary of resolution conditions.
Sucrose was added to the incubation mixture to a final concentration
of 10% (w/vol) and underlayed on a Sephacryl S-400 column matrix
that was equilibrated and eluted with 50 mM sodium phosphate pH 7.5,
5.3 M urea, 0.3 M NaCl, 0.2 mM EDTA, and 0.2 mg/ml Pluronic F-68.
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Absorbance of each fraction was measured at 280 nm (Figure 5) and
fractions with protein were dialyzed against 50 mM sodium phosphate
pH 7.5, 0.5 mM DTT, 0.2 mM EDTA, and 0.1 mg/ml aprotinin (a protease
inhibitor). Samples from each fraction were evaluated with on SDS-
PAGE and stained with Coomasie Blue. Appropriate fractions were
combined and pelleted at 190,000 g for 65 minutes. Pellets were
dissolved in same buffer as used in the dialysis step. At this stage
protein concentrations were determined by the BCA method and samples
were frozen in liquid nitrogen and stored at -70 C. The BCA method
of protein determination was preferred because it also could detect
protein at the low level we needed, was less time consuming and the
data were more reproducible than using the OPA protein measurement.
Figure 6 shows the resolution steps from PDC to E2-X-KcKb subcomplex
to the E2 oligomer.
Activity studies of E2 and E2Xj
Various catalytic properties of the E2 oligomer and of the
E2-Xj subcomplex, prepared free of the lipoyl domain of protein X
by protease arg C treatment by the procedure of Rahmattulah et al
[13], were compared to those of the untreated E2-X-KcKb subcomplex.
The E2 oligomer employed was essentially free of protein X
,
kinase
subunits and the E3 component which originally contaminated the E2-
X-K cKb subcomplex. Both E2 oligomer and E2-Xj had retained
transacetylation specific activity
#
At both 4° C and 22° C, the E2
oligomer had a reduced ability to serve as an acetyl acceptor in the
15
reductive acetylation reaction catalyzed by the El component. E2-Xj
subcomplex fully retained reductive acetylation activity (Table 3).
The E2 oligomer and E2-Xj subcomplex both enhanced the activity of
pyruvate dehydrogenase kinase and pyruvate dehydrogenase phosphatase
almost to the same extent as the E2-X (a form of subcomplex prepared
from E2-X-KcKb in which the kinase subunits were removed) [12] [17].
Both E2 and E2-Xj together with high levels of El and E3
components, had greatly diminished capacity to perform the overall
pyruvate dehydrogenase reaction CH3COCO2H + CoA-SH + NAD+ —
>
CH3CO-S-C0A + CO2 + NADH + H+ . This could result from denaturation
of some E2 subunits in the case of E2 oligomer but that would not
explain the decreased activity in the case of E2—Xj . This points to
a contribution of protein X (specifically its lipoyl domains) in PDC
reconstitution activity. This poses the question of the function of
protein X, and how it contributes (at least in part through its
lipoyl domains) to the overall reaction catalyzed by the pyruvate
dehydrogenase complex. Previous studies showed that E3 selectively
protected Protein X against protease action [13]. This brought into
question the binding properties of E3 to E2-Xj and the E2 oligomer.
Binding properties of E2 oligomer and E2-Xj
Binding assays were performed by combining E2-Xj
,
E2-X-KcKb,
and E2 oligomer with excess levels of E3 and pelleting these large
E2 containing structures through a three step sucrose gradient. The
idea was to see the amount of E3 bound to each of the E2 sources
after pelleting while keeping the free E3 in the supernatant. The
pellets were dissolved in SDS sample buffer and run on a SDS-PAGE.
Figure 7 shows that both E2 and E2-Xj had a reduced capacity to bind
E3 vs. the E2-X-KcKb subcomplex. The inner domain of protein X may
have a role but if Xj contributes it is inadequate alone. This
strongly suggests the lipoyl moiety of X is needed to bind E3.
Binding assays were performed using the El component by
combining it with E2—Xj f E2—X—
K
CK^ and E2 oligomer and pelleting.
In this case, El was retained in the pellets of all three E2 sources
with no significant differences in the ratio of binding (Figure
8). This suggests that the lipoyl domain of protein X is not
required to bind the El component to the subcomplex of pyruvate
dehydrogenase complex. This also indicates that the process of
preparation of the E2 oligomer did not alter the binding site on the
E2 subunit for the El component.
Interest was then turned to the fractions in the resolution
which came through the column directly after the fractions that
contained only E2. These later fractions were labeled X-E2 because
of the increased ratio of X to E2 compared to the E2-X-K
cKb
subcomplex. The ratios ranged from 1:2 up to 1:1 protein X to E2
as compared to 1:10 in E2-X-KcKb subcomplex. These levels were
estimated made from the relative staining of subunits following
separation by SDS-PAGE.
Transacetylation, reductive acetylation and reconstitution
assays were performed on the X-E2 fractions. All activities were
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greatly diminished compared to activities of the E2-X-KcKb
subcomplex. This led us to believe that the E2 component of these
X-E2 fractions was not native.
E3 binding properties of X deficient E2 sources
A microplate binding assay developed in our laboratory by S.
Gopalakrishnan was utilized to evaluate E3 binding to fractions
containing various levels of protein X. This included E2-X-KcK^
s
E2
oligomer, X-E2, and E2-Xj . These results (shown in Table 4) showed
that the X-E2 fraction had the highest capacity of binding E3,
almost three fold higher than that of E2—X—
K
CK^ subcomplex (this
based on the implied protein concentrations determined by the BCA
protein assay). The same X-E2 fraction had reduced capacity
(proportional to the E2 content) for binding ^?-El component [19].
This again showed that protein X contributes to the binding of the
E3 component
.
18
DISCUSSION
The E2-X subcomplex associates tightly with protein X and the
KcK|j components. In order to remove these components, chaotropic
agents (urea and NaCl) were used at a level high enough to separate
protein X away from E2 but also to retain transacetylation activity.
E2 retained the capacity to bind the El component as well as
stimulate PDH kinase and phosphatase [12]. At high levels of urea
and NaCl (exceeding 6.0 M and 0.5 M respectively), transacetylation
activity was diminished. At levels lower than 5.0 M urea with no
NaCl, the separation of protein X from E2 was not complete. In
order to get maximal results in both areas, transacetylation
activity and separation, exacting conditions were required.
After studying various conditions, the optimal treatment of
E2-X-KCKD subcomplex for resolution of the E2 oligomer was found to
be 0.35 M NaCl present in a 5.3 M urea buffer for both the
incubation and separation by gel filtration chromatography. Without
affecting the separation or transacetylation specific activity,
Pluronic F-68 block polymer was added to the column buffer to
increase the protein recovery from the column.
Significant native structure of the inner domain of E2 was
demonstrated by the oligomer formation and transacetylation activity
[13]. Other functions including El binding, kinase and phosphatase
activation required the outer domains of the E2 to retain native
structure [12] [13]. Decreased reductive acetylation activity was
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observed and may have resulted from damage to a portion of the outer
domain (specifically on the region of the lipoyl moieties that are
the substrate for this reaction). The structure of the lipoyl
domain is required for the reaction (free oxidized lipoamide does
not serve as a substrate for this reaction catalyzed by El).
Selective removal of the lipoyl domains of protein X by
treatment of E2-X-KcKb with protease Arg C can be achieved without
cleaving the E2 component [12]. The E2—Xj subcomplex retained
transacetylat ion specific activity, the ability to bind the El
component and fully activated the activities of the regulatory
enzymes [12] [14] and retained its capacity to serve as a substrate
for the El component in reductive acetylation. However, the E2-Xj
subcomplex had a reduced ability to perform the overall PDC reaction
(Table 3). Pelleting studies also showed a reduced affinity of E2-
Xj subcomplex for the E3 component. Since the removal of the lipoyl
domain is what led to these latter properties, it was not surprising
that I found in the same experiment that the removal of the entire
protein X also reduced the affinity of the E2 oligomer for the E3
component. Removal of protein X also caused lowered activity in the
overall PDC reaction although this result cannot be interpreted as
clearly as in the case of the E2-Xj subcomplex since there was a
reduction in the reductive acetylation reaction.
These data suggest that the E3 component of PDC associates
with protein X, mainly the outer or lipoyl domain. In the binding
studies, the only way that E3 could end up in the pellet is by
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binding with E2-X-KcKb since a control was run with E3 alone and
there was little or no E3 in the pellet material after centrif uging.
Looking at the E2-Xj subcomplex, very little E3 was in the pellet
material. Weak binding could give these results because E3
dissociates and would eventually cause it to be left behind in the
step gradient pelleting procedure. The microplate binding assay
detects this weak binding. Some E3 association may be due to the
incomplete cleavage by arg C of the lipoyl domains (Xl) of protein
X. These results point to the role of Xl portion of protein X being
involved in E3 binding. Further studies are needed to show that the
lipoyl domain of protein X is preferentially used by the E3
component in the dihydrolipoyl dehydrogenase reaction.
The E3 microplate binding assay also supported the
association of the E3 component with protein X (Table 4). The X-E2
complex (the ratio of protein X to E2 ( >Jtl) being relatively high
compared to E2-X-KcKb (1:10)) showed increased binding of the E3
component via the dihydrolipoyl dehydrogenase reaction. The E2
oligomer and E2 with low levels of protein X remaining showed lower
capacities for binding the E3 component as compared to E2-X-Kc K]-)>
Again this suggests that increased amounts of protein X increased
the capactiy to bind the E3 component. Since some E3 was bound in
the microplate binding assay by the E2 oligomer and E2-Xj
subcomplex, this may indicate that a domain in the E2 component
(possibly through the E23 domain) contributes to the E3 binding. In
some a-keto acid dehydrogenase complexes lacking a protein X, a
21
region of E2 subunits has been shown to contribute to the binding of
the E3 component. Rahmatullah et al [12] have shown that the E2g
region of the mammalian transacetylase contributes to binding the El
component
.
In summary, the evidence presented shows the association of
the E3 component to protein X. Removal of protein X from the E2
component reduces the capacity of the E2 oligomer to perform the
overall PDC reaction. The outer domains of protein X are required
for maximal binding capacity of the E3 component and for a maximal
efficiency in the reaction catalyzed by the mammalian pyruvate
dehydrogenase complex.
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Figure
—Li Coordinated reactions catalyzed bv pyruvate
dehydrogenase complex.
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Fi gure 2. SDS-PAGE of E2-X-KcKb resolution containing 5 M
urea. 1 mg E2-X-KcKb was incubated with 5.0M urea and 0.5 mM DTT
in 50 mM NaxP04 pH 7.5 for 60 minutes before applying to a gel
filtration column. 0.4 ml fractions were collected and numbering
started after collection of the void volume of eluent.
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Figure 3, SDS-PAGE of E2-X-K
cKb subcompl p.x resolution
containing 6 M urea, 1 mg E2-X-KcKb subcomplex was incubated with 6
M urea and 0.5 mM DTT in 50 mM NaxP04 pH 7.5 for 60 minutes before
applying to a gel filtration column. 0.4 ml fractions were
collected and numbering began after collection of the void volume of
eluent
.
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Fi gure 4. SDS-PAGE of E2 resolution containing 5.3 M urea.
lmg E2-X-KcKb was incubated with 5.3 M urea, 0.35 M NaCl , 0.5 M DTT
in 50 mM NaxP04 pH 7.5 for 60 minutes before applying to a gel
filtration column. 0.2 mg/ml Pluronics F-68 block polymer was added
to column buffer only. 0.4 ml fractions were collected and
numbering started after collection of the void volume.
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Figure 5. Typical E2 resolution profile. 1 mg E2-X-KcKb was
incubated in 5.3 M urea, 0.35 M NaCl , and 2.0 mM DTT for 120
minutes. 0.A ml fractions were collected and absorbance measured at
280 nm.
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Figure 6. Subunits of the bovine kidnev pyruvate dehydrogenase
complex, the E2-X-Kc Kfr subcomplex. and the E2 oligomer. The SDS-
PAGE pattern is shown (left to right) for 6 ug of complex, 4 ug of
E2-X-KCKD subcomplex and 3 Ug of the E2 oligomer.
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Fi gure 7. SDS-PAGE of the binding of the dihvdrolipovl
dehydrogenase (E3) component. Pellet (P) consisted of 5 ul of the
pellet fractions. Supernatant (S) consisted of 15 ul of the
supernatant fractions. A pattern for 10 ug of the kidney pyruvate
dehydrogenase complex is shown on the left side. Conditions for
binding were described in the Experimental Procedures section.
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Figure 8. SDS-PAGE of the binding of the pyruvate dehydrogenase
(El) component, Labeling was as described in Figure 7. Conditions
for binding were described in the Experimental Procedures section.
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Table 1. Recovery of E2 oligomer. E2—X—
K
CK^ subcomplex
starting material and resolved E2 oligomer were assayed to determine
transacetylation specific activity. E2 oligomer protein recovered
was measured using the BCA assay (see Experimental Procedures). The
total units were calculated of E2—X—
K
CK^ starting material and of
the E2 oligomer recovered.
E2 Source Specific Activity Recovery Total units
E2-X-K 7.7 umoles/min/mg 1.0 mg 7.7 umoles/min
(starting material)
E2 oligomer 1.27 umoles/min/mg 250 ug 0.32 umoles/min
(after pelleting)
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Table 2. Resolution procedure and results. A summary of the
various conditions and their results as reported in RESULTS.
Incubation Column
Mixture Buffer
(50 mM NaxPC>4 (50 mM NaxP04 Results
pH 7.5, 0.2 mM pH 7.5,0.5 mM
DTT) at 4° C DTT, 0.2 mM EDTA)
5.0 M Urea
60 minutes
5.0 M Urea
6.0 M Urea
60 minutes
5.5 M Urea
60 minutes
5.5 M Urea
0.35 M NaCl
60 minutes
5.5 M Urea
0.35 M NaCl
Pluronic F-68
(2 mg/ml)
60 minutes
5.3 M Urea
0.35 M NaCl
120 minute
6.0 M Urea
5.5 M Urea
5.5 M Urea
0.35 M NaCl
5.5 M Urea
0.35 M Nacl
Pluronic F—
6
(2 mg/ml)
5.3 M Urea
0.35 M NaCl
Pluronic F-68
(0.2 mg/ml)
Poor separation
Good Transaceylation
specific act.
Low PDC specific act.
Low yield
(400 Ug/lmg E2-X-K)
Good separation
Average Transacetyl
.
specific act.
Low PDC specific act.
Low yeild
(400 Ug/lmg E2-X-K)
Good separation
Good Transacetylation
specific act.
Low PDC specific act.
Low yield
(400 Ug/lmg E2-X-K)
Good separation
Good Transacetylation
specific act.
Low PDC specific act.
Low yield
(450 Ug/lmg E2-X-K)
Poor separation
Good Transacetylation
specific act.
Low PDC specific act.
Good yield
(700 Ug/lmg E2-X-K)
Complete separation
Good Transacetylation
specific act.
Low PDC specific act.
Good yield
(700 ug/lmg E2-X-K)
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Table 3. Comparison of the E2-X—
K
c Kfo subcomplex. E2-X j
subcomplex and E2 oligomer in the transacetylat ion reaction,
reductive acetvlation reaction, and the overall PDC reconstitution
reaction.
Reductive
Trans— Acetylation
E2 acetylation Overall PDC (nmol[2-14C] acetyl
source Reaction Reaction incorporated mg— *
)
(mol/min/mg) (mol/min/mg)
10s at 4°C 180s at 22°C
E2-X-K 3.6 18 9.2 13.8
E2-X
:
3.5 1.05 9.7 12.6
E2 Oligomer 4.0 0.73 4.1 6.9
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Table 4. Microplate binding assays on E2 sources with different
levels of protein X. E3 activity measured was based on implied
protein concentrations bound to plate determined by BCA assay (see
microplate binding assay protocol in Experimemtal procedures) [ 19]
.
E2
Source
Ug 32P-E1
bound per ug E2/X
retained
Dihydrolipoyl
Dehydrogenase
Activity
moles/min/ug
E2/X retained
E2 oligomer
E2-Xj subcomplex
E2—X—
K
cKb subcomplex
X-E2 fraction
0.58
0.57
0.62
0.22
5.0
6.7
13.5
44.7
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ABSTRACT
An oligomer ic transacetylase (E2) component was produced free
of protein X by resolution of the dihydrolipoyl transacteylase-
protein X-kinase (E2-X-KcKt,) subcomplex. The properties of this E2
oligomeric and a form of the subcomplex from which the lipoyl-
bearing domain of protein X (Xl) was removed were studied. The
subcomplex from which the Xl portion was removed and the oligomeric
E2 component, while retaining other catalytic and binding properties
of the native subcomplex, had greatly reduced capacities both to
bind the dihyrolipoyl dehydrogenase (E3) component and to support
the overall reaction of the complex (upon reconstitution with other
components). These results indicate that protein X through its Xj^
domain, contributes to the binding of the E3 component and to the
overall reaction of the pyruvate dehydrogenase complex.
i
